Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

INTRODUCTION: For patients with rheumatoid arthritis (RA) with an inadequate response to tumor necrosis factor inhibitors (TNFi), main options include cycling onto a different TNFi or switching to a biologic/targeted synthetic disease-modifying antirheumatic drug with a different mechanism of action...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliore, Alberto, Pompilio, Giuseppe, Integlia, Davide, Zhuo, Joe, Alemao, Evo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010806/
https://www.ncbi.nlm.nih.gov/pubmed/33854570
http://dx.doi.org/10.1177/1759720X211002682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010806/
https://www.ncbi.nlm.nih.gov/pubmed/33854570
http://dx.doi.org/10.1177/1759720X211002682

Ejemplares similares